| Website | jjdevcorp.com |
| Phone | (732) 524-3218 |
| Employees | |
| Description | venture capital |
Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson & Johnson.
| Company | Date | Round | Size | Participants |
| Neotract | 9/09 | Series B | $23.7M | 2 |
| Neurosearch | 8/09 | Unattributed | $14.3M | 1 |
| CoAxia | 6/09 | Series D | $21.5M | 6 |
| Catalyst Biosciences | 12/08 | Series C | $40M | 7 |
| Biolex Therapeutics | 10/08 | Series D | $60M | 12 |
| Metabolex | 4/07 | Series D | $32M | 16 |